
    
      The investigators select the postmenopausal patients with breast cancer who is confirmed by
      core needle biopsy and at the clinical stage T2-4N0-2M0.Treat them with 4 cycles of TAC as
      neoadjuvant chemotherapy (Docetaxel was 75mg/m2, the EPI 60mg/m2 and the CTX
      600mg/m2,21day/cycle).At the same time give daily oral exemestane 25mg for 12 weeks.Then
      assess the efficacy and safety of TAC and Exemestane.
    
  